Ozempic and Wegovy considered ‘available’ after more than two years in shortage
The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years ...
Medpage Today on MSN10h
Wegovy Reduced Pain From Knee Osteoarthritis
Semaglutide (Wegovy) reduced pain and improved physical function in patients with obesity and knee osteoarthritis, a ...
Does Compounded Semaglutide Work for Weight Loss?
Compounded semaglutide can be an affordable alternative to brand-name weight loss injections like Ozempic and Wegovy. But ...
Hims & Hers stock falls 14% after FDA changes semaglutide supply status (update)
Hims & Hers (HIMS) stock fell 14% following news that Novo Nordisk’s (NVO) weight-loss drug Wegovy is no longer ...
STAT9h
Wegovy reduces knee pain in osteoarthritis patients with obesity, study finds
Wegovy reduced arthritic knee pain in study subjects with high BMI. Unknown: the exact mechanism or whether it would prevent knee replacement surgery.
HealthDay on MSN6d
Ozempic, Wegovy Might Help Lower Alzheimer's Risk in People With Diabetes
Add Alzheimer’s disease to the list of conditions that might benefit from the revolutionary diabetes drug Ozempic, a ...
STAT14h
Novo Nordisk’s Ozempic and Wegovy, long in shortage, are now listed as available by FDA
Semaglutide, the scientific name for Novo’s GLP-1 diabetes drug Ozempic and obesity drug Wegovy, has been on the shortage ...
MedPage Today on MSN2d
Wegovy Cut Albuminuria by Half in Non-Diabetic CKD
Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN ...
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
It is a sign that Novo Nordisk’s efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to ...
Semaglutide linked to reduced arthritis knee pain in people with obesity, study finds
People who lost a significant amount of weight with semaglutide saw major improvements in osteoarthritis knee pain, research published Wednesday in the New England Journal of Medicine finds.
Ozempic, Wegovy move closer to no longer being in shortage, FDA says
Both Ozempic and Mounjaro are approved by the FDA to treat Type 2 diabetes, but some doctors prescribe the medication "off-label" for weight loss, as is permissible by the FDA.